Pulse Biosciences (PLSE) Short Interest Ratio & Short Volume $17.98 +0.19 (+1.07%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Pulse Biosciences Short Interest DataPulse Biosciences (PLSE) has a short interest of 2.12 million shares, representing 12.40% of the float (the number of shares available for trading by the public). This marks a 1.92% increase in short interest from the previous month. The short interest ratio (days to cover) is 12.9, indicating that it would take 12.9 days of the average trading volume of 200,640 shares to cover all short positions.Current Short Interest2,120,000 sharesPrevious Short Interest2,080,000 sharesChange Vs. Previous Month+1.92%Dollar Volume Sold Short$45.37 millionShort Interest Ratio12.9 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares61,517,000 sharesFloat Size17,100,000 sharesShort Percent of Float12.40%Today's Trading Volume166,773 sharesAverage Trading Volume200,640 sharesToday's Volume Vs. Average83% Short Selling Pulse Biosciences? Sign up to receive the latest short interest report for Pulse Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPLSE Short Interest Over TimePLSE Days to Cover Over TimePLSE Percentage of Float Shorted Over Time Ad ProsperityPubThis Indicator called BOTH NVDA ralliesRarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. Pulse Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20242,120,000 shares $45.37 million +1.9%12.4%12.9 $21.40 11/15/20242,080,000 shares $34.61 million -18.1%12.2%12.2 $16.64 10/31/20242,540,000 shares $44.27 million -7.6%14.9%15.9 $17.43 10/15/20242,750,000 shares $45.07 million -0.7%16.2%17.2 $16.39 9/30/20242,770,000 shares $48.59 million +0.7%16.3%14.8 $17.54 9/15/20242,750,000 shares $50.90 million -1.8%16.1%11.8 $18.51 Get the Latest News and Ratings for PLSE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/31/20242,800,000 shares $52.19 million -4.8%16.5%12.2 $18.64 8/15/20242,940,000 shares $56.12 million +1.0%17.3%11.3 $19.09 7/31/20242,910,000 shares $43.53 million +3.9%23.9%10.8 $14.96 7/15/20242,800,000 shares $54.63 million +12.0%23.0%10.5 $19.51 6/30/20242,500,000 shares $27.98 million +2.9%15.3%9.9 $11.19 6/15/20242,430,000 shares $29.23 million -14.4%14.9%11 $12.03 5/31/20242,840,000 shares $32.80 million -3.1%17.4%13.2 $11.55 5/15/20242,930,000 shares $21.27 million +3.9%17.9%15.8 $7.26 4/30/20242,820,000 shares $20.78 million -3.1%17.4%16.9 $7.37 4/15/20242,910,000 shares $22.76 million +10.7%18.0%17 $7.82 3/31/20242,630,000 shares $22.91 million +5.2%16.2%14.6 $8.71 3/15/20242,500,000 shares $25.78 million -2.7%15.5%13 $10.31 2/29/20242,570,000 shares $25.39 million -1.2%15.9%10.3 $9.88 2/15/20242,600,000 shares $23.92 million -1.1%16.1%9.1 $9.20 1/31/20242,630,000 shares $23.35 million +6.5%16.3%9 $8.88 1/15/20242,470,000 shares $19.83 million +5.1%15.3%8.5 $8.03 12/31/20232,350,000 shares $28.76 million -8.2%14.5%8.7 $12.24 12/15/20232,560,000 shares $25.19 million +7.1%N/A10.2 $9.84 11/30/20232,390,000 shares $21.58 million +2.6%N/A12.2 $9.03 11/15/20232,330,000 shares $14.87 million +8.4%N/A12.8 $6.38 10/31/20232,150,000 shares $9.72 million +3.9%N/A11.5 $4.52 10/15/20232,070,000 shares $8.40 million -2.8%N/A11.2 $4.06 9/30/20232,130,000 shares $8.58 million +4.9%N/A11.6 $4.03 9/15/20232,030,000 shares $9.50 million +8.0%N/A11.5 $4.68 8/31/20231,880,000 shares $8.85 million +9.9%N/A9.2 $4.71 8/15/20231,710,000 shares $13.54 million +0.6%N/A10.8 $7.92 7/31/20231,700,000 shares $13.43 million -5.0%N/A12.3 $7.90 7/15/20231,790,000 shares $12.53 million -4.3%N/A12.7 $7.00 6/30/20231,870,000 shares $13.45 million +17.6%N/A12.3 $7.19 6/15/20231,590,000 shares $10.35 million +3.3%N/A10 $6.51 5/31/20231,540,000 shares $9.55 million -8.3%25.8%13.6 $6.20 5/15/20231,680,000 shares $13.46 million -6.2%28.1%16.3 $8.01 4/30/20231,790,000 shares $11.53 million -5.3%11.4%20.4 $6.44 4/15/20231,890,000 shares $10.92 million -4.1%12.0%27 $5.78Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover 3/31/20231,970,000 shares $6.62 million -5.7%12.5%30.2 $3.36 3/15/20232,090,000 shares $6.60 million +4.5%13.4%38 $3.16 2/28/20232,000,000 shares $5.46 million -5.7%12.8%26.5 $2.73 2/15/20232,120,000 shares $6.21 million -3.2%13.6%26.9 $2.93 1/31/20232,190,000 shares $6.85 million -1.8%14.0%26.2 $3.13 1/15/20232,230,000 shares $8.65 million +4.2%14.3%25.5 $3.88 12/30/20222,140,000 shares $5.93 million -5.3%13.7%23.8 $2.77 12/15/20222,260,000 shares $5.70 million -6.6%14.5%10 $2.52 11/30/20222,420,000 shares $4.84 million -1.2%15.6%10.5 $2.00 11/15/20222,450,000 shares $5.07 million +7.9%15.8%11.3 $2.07 10/31/20222,270,000 shares $4.79 million +1.3%14.7%10.1 $2.11 10/15/20222,240,000 shares $5.06 million +9.8%14.5%9.8 $2.26 9/30/20222,040,000 shares $4.69 million +6.3%13.2%8.9 $2.30 9/15/20221,920,000 shares $2.86 million +1.1%12.4%10.4 $1.49 8/31/20221,900,000 shares $2.41 million +2.7%12.3%15.8 $1.27 8/15/20221,850,000 shares $3.27 million +1.1%11.9%14.1 $1.77 7/31/20221,830,000 shares $2.85 million -3.7%11.8%11.6 $1.56 7/15/20221,900,000 shares $3.80 million No Change13.3%10.1 $2.00 6/30/20221,900,000 shares $2.91 million -21.2%21.8%7.9 $1.53 6/15/20222,410,000 shares $4.94 million -15.4%34.5%9.5 $2.05 5/31/20222,850,000 shares $6.36 million -0.7%22.0%12.1 $2.23 5/15/20222,870,000 shares $4.88 million +2.9%22.2%11.4 $1.70 4/30/20222,790,000 shares $6.98 million +12.5%21.8%10.9 $2.50 4/15/20222,480,000 shares $8.61 million -4.3%19.3%9.7 $3.47 3/31/20222,590,000 shares $12.59 million +2.0%20.3%13.6 $4.86 3/15/20222,540,000 shares $11.84 million +7.2%19.9%15.4 $4.66 2/28/20222,370,000 shares $12.04 million +13.4%18.6%15.5 $5.08 2/15/20222,090,000 shares $13.73 million +13.0%16.4%15.2 $6.57 1/31/20221,850,000 shares $22.50 million +7.6%14.5%17.2 $12.16 1/15/20221,720,000 shares $21.38 million +4.9%13.5%24.4 $12.43 12/31/20211,640,000 shares $24.29 million +4.5%12.9%30.3 $14.81 12/15/20211,570,000 shares $26.71 million +6.1%12.3%31.6 $17.01 11/30/20211,480,000 shares $30.04 million +1.4%11.6%30.2 $20.30 11/15/20211,460,000 shares $31.65 million No Change11.5%31.1 $21.68 10/29/20211,460,000 shares $30.79 million +1.4%11.5%28.1 $21.09 10/15/20211,440,000 shares $31.18 million -2.0%11.3%25.6 $21.65 9/30/20211,470,000 shares $31.75 million -6.4%11.5%23.3 $21.60 9/15/20211,570,000 shares $32.26 million -1.9%12.3%14.2 $20.55 8/31/20211,600,000 shares $41.44 million +0.6%12.6%15 $25.90 8/13/20211,590,000 shares $35.66 million +3.9%14.8%15.5 $22.43 7/30/20211,530,000 shares $31.37 million +7.0%16.0%14.4 $20.50 7/15/20211,430,000 shares $25.93 million +7.5%14.9%13.6 $18.13 6/30/20211,330,000 shares $21.81 million -5.0%13.9%12.6 $16.40 6/15/20211,400,000 shares $24.15 million +3.7%11.1%20.8 $17.25 5/28/20211,350,000 shares $24.35 million -2.9%10.7%17.2 $18.04 5/14/20211,390,000 shares $23.84 million +12.1%11.0%15.2 $17.15 4/30/20211,240,000 shares $25.11 million +1.6%9.9%11.2 $20.25 4/15/20211,220,000 shares $26.24 million -6.2%9.8%9.3 $21.51 3/31/20211,300,000 shares $29.51 million +0.8%10.3%8.9 $22.70 3/15/20211,290,000 shares $39.82 million +6.6%10.2%8.3 $30.87Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover 2/26/20211,210,000 shares $35.08 million +8.0%9.6%8 $28.99 2/12/20211,120,000 shares $40.36 million -10.4%9.5%7.7 $36.04 1/29/20211,250,000 shares $43.04 million -22.4%9.9%9.3 $34.43 1/15/20211,610,000 shares $40.02 million -16.6%12.7%14.1 $24.86 12/31/20201,930,000 shares $47.29 million -9.8%15.2%20.9 $24.50 12/15/20202,140,000 shares $40.23 million -7.8%16.4%22.2 $18.80 11/30/20202,320,000 shares $34.10 million -0.4%17.8%24 $14.70 11/15/20202,330,000 shares $34.62 million No Change18.0%24.2 $14.86 10/30/20202,330,000 shares $28.10 million +0.9%18.0%24.8 $12.06 10/15/20202,310,000 shares $35.14 million -2.1%17.9%25.2 $15.21 9/30/20202,360,000 shares $27.82 million -2.1%18.3%25.4 $11.79 9/15/20202,410,000 shares $28.12 million -0.8%18.7%29.4 $11.67 8/31/20202,430,000 shares $24.03 million -5.5%18.8%26.9 $9.89 8/14/20202,570,000 shares $26.99 million -0.8%20.0%27.8 $10.50 7/31/20202,590,000 shares $26.55 million -3.7%20.2%22.4 $10.25 7/15/20202,690,000 shares $26.77 million -1.5%20.9%18.7 $9.95 6/30/20202,730,000 shares $28.97 million -1.4%26.4%19 $10.61 6/15/20202,770,000 shares $23.05 million +9.1%26.8%19.5 $8.32 5/29/20202,540,000 shares $24.13 million +6.7%22.6%18.5 $9.50 5/15/20202,380,000 shares $27.27 million -7.4%21.1%17.8 $11.46 4/30/20202,570,000 shares $28.86 million -1.5%22.9%18.4 $11.23 4/15/20202,610,000 shares $17.25 million -4.7%23.2%25.1 $6.61 3/31/20202,740,000 shares $21.73 million +0.7%24.6%27.1 $7.93 3/13/20202,720,500 shares $18.99 million +4.2%24.5%34.3 $6.98 2/28/20202,610,000 shares $15.06 million +11.5%23.5%32.7 $5.77 2/14/20202,340,000 shares $16.64 million +0.4%21.1%30.6 $7.11 1/31/20202,330,000 shares $15.94 million -5.3%21.0%46.8 $6.84 1/15/20202,460,000 shares $33.83 million +1.2%22.2%49.7 $13.75 12/31/20192,430,000 shares $34.55 million +1.7%21.9%48.5 $14.22 PLSE Short Interest - Frequently Asked Questions What is Pulse Biosciences' current short interest? Short interest is the volume of Pulse Biosciences shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 2,120,000 shares of PLSE short. 12.40% of Pulse Biosciences' shares are currently sold short. Learn More on Pulse Biosciences' current short interest. What is a good short interest ratio for Pulse Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PLSE shares currently have a short interest ratio of 13.0. Learn More on Pulse Biosciences's short interest ratio. What is a good short interest percentage for Pulse Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.40% of Pulse Biosciences' floating shares are currently sold short. Is Pulse Biosciences' short interest increasing or decreasing? Pulse Biosciences saw a increase in short interest in the month of November. As of November 30th, there was short interest totaling 2,120,000 shares, an increase of 1.9% from the previous total of 2,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Pulse Biosciences' float size? Pulse Biosciences currently has issued a total of 61,517,000 shares. Some of Pulse Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Pulse Biosciences currently has a public float of 17,100,000 shares. How does Pulse Biosciences' short interest compare to its competitors? 12.40% of Pulse Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Pulse Biosciences: PROCEPT BioRobotics Co. (11.85%), Axonics, Inc. (6.48%), NovoCure Limited (5.78%), Envista Holdings Co. (6.51%), Inari Medical, Inc. (4.99%), iRhythm Technologies, Inc. (6.77%), LivaNova PLC (4.25%), Enovis Co. (7.65%), Warby Parker Inc. (15.50%), CONMED Co. (7.80%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Pulse Biosciences stock? Short selling PLSE is an investing strategy that aims to generate trading profit from Pulse Biosciences as its price is falling. PLSE shares are trading up $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pulse Biosciences? A short squeeze for Pulse Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PLSE, which in turn drives the price of the stock up even further. How often is Pulse Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PLSE, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies PRCT Short Interest AXNX Short Interest NVCR Short Interest NVST Short Interest NARI Short Interest IRTC Short Interest LIVN Short Interest ENOV Short Interest WRBY Short Interest CNMD Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PLSE) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
